Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Relay Therapeutics
Biotech
Relay ‘full steam ahead’ on PI3K drug after rare disease readout
Relay’s R&D chief remains convinced zovegalisib will carve out its own niche after reporting early phase 2 data in patients with vascular anomalies.
Will Maddox
May 19, 2026 6:00am
Relay starts 3rd layoff wave in one year, shedding 70 staffers
Apr 4, 2025 11:30am
Elevar offers $500M biobucks for Relay's rare cancer asset
Dec 3, 2024 3:04pm
Relay sheds 10% of staff after earlier layoffs in July
Oct 3, 2024 4:23pm
Relay breast cancer data tee up clash with AstraZeneca's Truqap
Sep 9, 2024 7:00am
Relay loses interest in SHP2 inhibitor after Genentech leaves
Aug 7, 2024 6:00am
